Background: Neurons project their axons along specific pathways in order to establish appropriate connections with their target cells. The rate and direction of axonal growth is determined by interactions between the highly motile growth cone and environmental cues that can act in either an attractive or a repulsive manner. Locomotion is ultimately dependent upon the reorganisation of the actin cytoskeleton and an established role for the Rho family of small GTPases in regulating this process in non-neuronal cells identifies them as candidate signalling molecules in growth cones. An inactive form of Rac1 has recently been shown to inhibit the 'growth-cone collapse' response induced by chick Sema3A, a protein that has recently been established as an important guidance cue. The molecular basis for this inhibition remains unclear.
Background
Neuronal growth cones navigate along specific pathways to establish the appropriate connections between neurons and their target cells. The rate and direction of growth is determined by interactions between the growth cone and environmental cues that can act either in a positive (attractive) or negative (repulsive/inhibitory) manner (reviewed in [1] ). Locomotion is ultimately dependent upon the reorganisation of the cytoskeleton, especially its cortical actin meshwork, in lamellipodia and filopodia [2] .
Prospective intracellular mediators of guidance signals are members of the Rho family of small GTPases [2, 3] . There are at least 14 distinct Rho GTPases in mammalian cells; the best characterised are Cdc42, Rac1 and RhoA. During the past decade their effects on the organisation of the actin cytoskeleton in mammalian fibroblasts have been established; Cdc42 triggers the formation of filopodia, Rac1 regulates the formation of lamellipodia and RhoA triggers assembly of focal contacts and stress fibres. More recently, the involvement of Rho GTPases in the regulation of the actin cytoskeleton in response to external stimuli has also been demonstrated in macrophages and neurons. Additional roles, including the regulation of gene expression and cell proliferation, have also recently been revealed (reviewed in [4] [5] [6] ).
The activity of Rho GTPases is regulated by the antagonistic actions of guanine-nucleotide exchange factors (GEFs), which load G proteins with GTP and thus activate them, and GTPase-activating proteins (GAPs), which activate the intrinsic GTPase activity of G proteins and thus return them to the inactive state. In addition, the GTPases interact with so-called effector proteins, which are the downstream targets that mediate the effects of the GTPases (reviewed in [4] [5] [6] ). Some of the Cdc42-and/or Rac1-binding proteins (for example the kinases PAK, ACK and MLK2/3 and the Wiskott-Aldrich syndrome protein WASP) contain a consensus sequence motif (CRIB, for Cdc42/Rac1 interactive binding [7] ), which is believed to mediate the interaction. Others (for example Citron, S6 kinase, POR-1, p35, and phosphatidylinositol 3-kinase (p85 PI3K )) evidently lack the CRIB sequence and bind through a different motif [8] . Different effectors or sets of effectors are thought to mediate the diverse effects of Rho GTPases.
Point mutations in Rho proteins can abolish interactions with their specific downstream effectors and this has been used to test the requirement for individual effectors in biological responses [9] , an approach first described for the analysis of Ras targets [10] . The mutations are generally introduced in the context of constitutively active forms of the GTPase (for example the V12 mutation), which, by design, are uncoupled from upstream stimuli. This approach is therefore limited, as it does not permit the study of GTPase-effector interactions in response to a specific external stimulus. Such studies would greatly benefit from the development of cell-permeable agents that can compete with downstream effector molecules for binding to GTPases. Identification of amino-acid sequences involved in binding of the GTPase to the effector would enable the development of competitive peptide mimics, provided that these peptides could be introduced into cells. One way of achieving this could be fusion of peptides to a 16 amino-acid region of the Antennepedia homeodomain protein (also known as Penetratin) which has been shown to allow delivery of peptides into living cells [11] .
We have used the experimental paradigm of the growthcone collapse response induced by the repulsive axon guidance molecule Sema3A to investigate the role of GTPases in the regulation of the actin cytoskeleton in neurons [12] . Sema3A (also known as collapsin-1) is a member of the Class III semaphorin family of secreted molecules that act as repulsive factors for particular axonal populations. The binding of Sema3A to the transmembrane receptor neuropilin-1 is required for the collapse response [13, 14] ; however, neuropilins lack any evident signalling motifs and thus the nature of the signalling is obscure. Nevertheless, two recent reports have demonstrated that Sema3A-induced growth-cone collapse is blocked by expression of an inactive form of Rac1 (N17Rac1), which is presumed to act as a specific dominant-negative mutant [15, 16] . The involvement of Cdc42 in the collapse response is unclear, as the two reports offer contradictory results on this point. To clarify the role of different Rho GTPases and effector molecules in growthcone collapse we have developed cell-permeable peptide inhibitors of GTPase-effector interactions. We have approached the problem from both the GTPase and the effector side by designing cell-permeable peptides that correspond either to overlapping fragments of the Rac1 effector-binding domain, or to CRIB motifs from the Rac1 and/or Cdc42 effector molecules PAK and N-WASP. These peptides have been tested for their ability to bind to GTPases and/or GTPase effectors, and for their ability to inhibit the growth-cone collapse response.
Results

Peptide 17-32 from Rac1 interacts with Rac1 targets and inhibits growth-cone collapse
On the basis of their similarity to the more distant relative Ras, Rho GTPases are likely to bind to their targets via the amino-terminal third of the molecule. This includes a region that undergoes conformational change on GDP/GTP switching and is known as the effector loop. Specific point mutations in this region affect the target specificity of the GTPase. It is, however, unclear whether these amino acids are directly involved in the GTPase-target contacts or whether they change the GTPase conformation. Rac1, Cdc42, RhoA and Ras have a high degree of sequence identity. There are, however, also distinct differences in sequence, which are likely to be responsible for the fact that the molecules interact with different effectors, and are obvious candidates for the development of specific inhibitors ( Figure 1 ). We decided to target the interactions of Rac1 as it is the GTPase most clearly implicated in Sema3A signalling. We synthesised a set of four overlapping peptides covering amino acids 17-56 of Rac1 ( Figure 1 ). All peptides were synthesised in tandem with the Penetratin internalisation sequence, and had an aminoterminal biotin for detection and immobilisation. We tested the peptides for their ability to bind to known Rac1-interacting molecules -PAK, WASP, 3BP-1, p85β PI3K and p67 Phox . Using bacterially produced purified GST fusion proteins of the GTPase-binding domains (GBD) of PAK, WASP, p85β PI3K and p67 Phox we found that, whereas GST-p67 Phox1-238 failed to interact with any of the peptides, the others bound specifically to the peptide encompassing amino acids 17-32 of Rac1 (Figure 2a) . Furthermore, we were also able to show that the same peptide interacted with endogenous 3BP-1 in Swiss 3T3 cell lysates (Figure 2a) . In addition, we tested the four peptides for their ability to compete with Rac1 for binding to PAK. Lysates from COS cells expressing activated Rac1 (V12 mutants) were incubated with immobilised GST-PAK in the absence or presence of Rac1 peptides. In agreement with the above results, only the 17-32 peptide inhibited binding of Rac1 to GST-PAK (Figure 2b ). Thus we can conclude that a short linear peptide from Rac1 specifically binds target proteins, and that it effectively competes with intact activated Rac1 for binding to a target. PAK can also interact with active Cdc42, and it is therefore not surprising that the Rac1-derived PAK-binding peptide can compete with Cdc42 for PAK binding, albeit to a lesser degree (Figure 2b ).
The effect of the Rac1 peptides on growth-cone collapse was studied using explants of embryonic day 7 (E7) chick dorsal root ganglia (DRG). Treatment of DRG explants with an Fc chimeric version of Sema3A (see [17] for details) caused an increase in the number of collapsed growth cones from the basal level of 15% to around 80% ( Figure 3 ). Peptides added at 40 µg/ml to DRG explants had no significant effect on the basal level of collapsed growth cones ( Figure 3 ), nor did they cause any evident change in growth-cone morphology (data not shown). However, the Rac1 17-32 peptide dramatically inhibited the growth-cone collapse induced by treatment with Sema3A ( Figure 3 ). In contrast, the other three Rac1-derived peptides had no effect on the collapse response. Thus there is a clear correlation between the ability of Rac1 peptides to bind to targets and compete for a Rac1-effector interaction and their ability to inhibit the growth-cone collapse response.
We made an equivalent set of peptides from Cdc42 and tested them in parallel in the biochemical assay. The Cdc42 17-32 peptide was indistinguishable from Rac1 17-32 in that it bound to the same tested targets and competed with either Rac1 or Cdc42 for binding to GST-PAK 65-137 ( Figure 2 ). This is perhaps not surprising considering the high degree of sequence identity between these two peptides (14 out of 16 residues, Figure 1a ).
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Figure 1
The Rac1 peptides used in the present study. (a) Alignment of amino-termini of c-Ha-Ras, RhoA and Cdc42 with Rac1. Identical aminoacid residues are boxed. The sequence of Rac1-derived peptides is shown below the alignment. All the peptides contain aminoterminal biotin, ε-amino hexanoic acid (εAhx) and the Penetratin internalisation sequence (underlined). Biotin allows capture and detection of the peptides and εAhx functions as a spacer. Colour coding identifies the location on the peptides on the threedimensional structure of Rac1 (b). The structure is based on coordinates published by Hirshberg et al. [30] . Current Biology
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Figure 2
Interaction of Rac1-derived peptides with Rac1-binding proteins.
(a) Affinity precipitation of GST-p67 
What is perhaps surprising, however, is the observation that this peptide had little or no effect on the growth-cone collapse response ( Figure 3) .
A CRIB-motif peptide from PAK interacts with GTPases and blocks the collapse response
The Rac1 17-32 peptide can bind to Rac1-interacting proteins and thus outcompetes the binding of the target protein to activated Rac1. However, given that some effectors use the same binding domain (for example CRIB) to interact with a subset of GTPases, one would expect that the Rac1-derived peptide would also compete for effector binding to other GTPases. To complement the above approach, we designed effector-based peptides that would be expected to outcompete GTPase-target interactions by binding back to the GTPase itself. A number of structures (for example Dbl and Bcr/GAP homology domains and CRIB) bind to GTPases [7, 18] , with the CRIB motif being of particular interest in that it is a relatively short linear sequence. On the basis of published reports, CRIB motifs from different molecules may have distinct specificities for GTPases. For example, PAK has been reported to bind to both Rac1 and Cdc42 [7] , whereas N-WASP has been reported to bind only to Cdc42 [19] . We therefore synthesised biotinylated peptides of 16 amino acids, based on the CRIB motifs from PAK or N-WASP in tandem with the Penetratin internalisation vector (Figure 4 ).
The PAK and N-WASP CRIB peptides were tested for their ability to bind directly to activated RhoA, Rac1 and Cdc42 (Figure 5a ). In agreement with their known specificities (see above), both peptides interacted with activated Cdc42, the PAK peptide also interacted with Rac1, and none of the peptides interacted with RhoA. As an additional control, the peptides showed no direct interaction when the PAK and N-WASP sequences were reversed (BIRC peptides, see Figure 5a ). We next determined whether the 'target'-derived peptides could compete for activated GTPase-target interactions. Interaction of PAK with Cdc42 in transfected COS cell lysates was clearly inhibited by both PAK and N-WASP CRIB peptides (Figure 5b ). PAK binding to Rac1 was also inhibited by both peptides (Figure 5b ), and this was perhaps unexpected given that we could not detect a direct interaction between the N-WASP CRIB peptide and Rac1. However, the competition assay would be expected to be more sensitive than a direct precipitation assay. As a control, the BIRC peptides had little or no effect on the GTPase-PAK interaction.
The peptides were further tested in the growth-cone collapse assay. On their own, the PAK and N-WASP CRIB peptides had no effect on the basal numbers of collapsed
Figure 3
The Rac1 17-32 peptide inhibits Sema3A-induced growth-cone collapse. Dorsal root ganglia (DRG) explants from E7 chick embryos were cultured in the presence of nerve growth factor (NGF) for 20-24 h. Peptides were added to a final concentration of 40 µg/ml for 1 h. Sema3A-Fc chimeric protein was added to a concentration of 1 µg/ml for 30 min. The data are from at least three independent experiments with duplicate samples. growth cones in the cultures. Interestingly, whereas the PAK CRIB peptide substantially inhibited the growthcone collapse response, the N-WASP CRIB peptide had no effect ( Figure 6 ). We used the biotin tag to localise both CRIB peptides in growth cones, and the results suggest that both are internalised to a similar extent (Figure 6b ). This indicates that their differential effect on growth-cone collapse is unlikely to be caused by differences in internalisation efficiency. Surprisingly, both of the BIRC peptides induced the collapse of a small percentage of the growth cones under control conditions, with the PAK BIRC peptide also showing a marginal inhibitory effect towards Sema3A. These less than substantial effects are likely to be non-specific.
Discussion
The traditional method of establishing an involvement of Rac1 and Cdc42 in a particular physiological or cellular process is to overexpress inactive mutants of the proteins. This approach has been used successfully in numerous model and assay systems. These mutants are believed to function by sequestering GEFs and thus outcompeting the activation of endogenous GTPases in a dominant-negative manner. However, this approach does not allow the dissection of events downstream of GTPase activation, and is compromised by the fact that subsets of GTPases can use the same GEFs. The involvement of distinct signalling molecules has been studied using constitutively active GTPases with specific point mutations in the region that affects their interactions with downstream molecules. However, as this approach uses GTPases that have been uncoupled from upstream regulators, it is of limited applicability.
Another possible caveat to this approach is the delivery technique itself. Especially with small delicate structures like growth cones, an invasive technique such as microinjection is not ideal. In addition, it is laborious and technically hard to microinject a large number of cells. Thus investigation of GTPase-effector interactions would greatly benefit from the development of novel inhibitors, that could be delivered into the cells in a passive manner. Mimetic peptides, based on linear interaction sites, are useful pharmacological tools for the study of protein-protein interactions because they can act as competitive inhibitors. This approach has been used, for example, in disrupting the interactions of proteins containing Src homology 2 (SH2) or phosphotyrosine-binding (PTB) domains with tyrosinephosphorylated proteins [20] [21] [22] , and of SH3-containing molecules with proline-rich proteins [23] . Similarly, a peptide from the Ras effector area has been shown to inhibit interaction of Raf with Ras [24] . However, whereas phosphotyrosine-containing peptides have been shown to interact with SH2 and PTB domains in a very stable manner, to our knowledge there has been no demonstration of direct binding between a small fragment of a GTPase and an interacting protein. As GTPases are supposed to bind their effector molecules only in their active GTP-loaded state, and as there is no modification of the protein primary structure, one might expect that the GTPase-derived peptides would not bind to the target molecules stably, if at all. However, we have demonstrated here by affinity precipitation, the interaction of 17-32 peptides from Rac1 and Cdc42 with various target molecules, and this suggests that these interactions are relatively stable. The interactions were specific in that three other Rac1 peptides failed to interact with any of these molecules, and the 17-32 peptides did not bind to another Rac1 target, p67 Phox . In the case of PAK at least, the 17-32 peptide is clearly interacting with the Rac1-binding site on PAK (presumably the CRIB site), as it could also completely inhibit the binding of activated Rac1 to PAK. Interestingly, a mutation of Tyr40 in activated Rac1 (and Cdc42) disrupts binding to PAK [9] , suggesting additional contacts between Rac1 and PAK. Indeed, recently Research Paper Rac1 in Sema3A signalling Västrik et al. 995
Figure 6
The PAK CRIB peptide inhibits Sema3A-induced growth-cone collapse. (a) DRG explants from E7 chick embryos were cultured in the presence of NGF for 20-24 h. Peptides were added to a final concentration of 40 µg/ml for 1 h. Sema3A-Fc was added to a concentration of 1 µg/ml for 30 min. The data are from at least five independent experiments. (b) Staining for internalised PAK and N-WASP CRIB peptides in the growth cones. Overnight cultures of DRG explants were treated with 40 µg/ml of indicated peptides for 1 h, washed and fixed. Peptides were visualised with streptavidin-TRITC. resolved solution structures of Cdc42 with the GTPasebinding domains of WASP [25] and ACK [26] support the idea of a relatively large interaction face that does indeed include residues 17-32 and Tyr40. However, two additional Rac1 peptides that contain Tyr40 failed to bind PAK and were unable to inhibit the Rac1-PAK interaction. This suggests that although the region around Tyr40 might be required for binding, it is not sufficient for binding. In contrast, the 17-32 region is clearly both required and sufficient for binding.
An almost identical sequence to the Rac1 17-32 motif is present in Cdc42, and both these GTPases interact with the CRIB motif of PAK (and of several other targets). It is perhaps not surprising that the Rac1 peptide (which should bind to the CRIB motif of PAK) can also inhibit the binding of Cdc42 to PAK, nor is it surprising that the Cdc42 17-32 peptide can outcompete the binding of Rac1 to PAK. However, what is interesting is that both the Rac1 and Cdc42 17-32 peptides are much less effective at inhibiting the Cdc42-PAK interaction relative to the Rac1-PAK interaction. One possibility is that Cdc42 interactions with its targets are more difficult to compete with because Cdc42 uses a larger face than Rac1 to bind the same target molecule. Indeed, the three-dimensional structures of Cdc42 with WASP [25] and ACK [26] both point to a relatively large interaction face. Furthermore, in a series of pull-down experiments we have observed that additional Cdc42 effector loop peptides (for example the 33-48 peptide) can pull down the same targets as the 17-32 peptide (I.V., unpublished observation), whereas in the case of Rac1, we only found binding activity with the 17-32 peptide.
Somewhat surprisingly we found that four out of the five proteins tested interacted with the 17-32 region of Rac1 and Cdc42. This demonstrates that both CRIB and Bcr/GAP homology domains interact with the same region of Rac1. As the 17-32 peptide inhibited the growth-cone collapse response, any of these interacting molecules might be important in Sema3A signalling. However, as dominant-negative Rac1 has been shown to block collapse, thus indicating a requirement for active Rac1 in the process [15, 16] , and as 3BP-1 inhibits Rac1 [27] , inhibition of 3BP-1 (or GAPs in general) by a peptide is not likely to explain its mechanism of action. Furthermore, the ability of Cdc42 17-32 peptide to bind to the very same targets while not inhibiting the collapse response strongly suggests that none of the tested targets is important in Sema3A-induced growth-cone collapse. An obvious possibility is that an alternative Rac1-specific effector molecule is required for the collapse response, and could interact exclusively with the Rac1 peptide. However, we cannot rule out the possibility that the differential effect of Rac1 and Cdc42 17-32 peptides in the collapse assay is due to differences in the binding kinetics to a common target which are too subtle to be picked up in our biochemical assays.
If Rac1 function is indeed required for the collapse response, a peptide from a target molecule which is able to bind back to the effector loop of Rac1 should act as a competitive inhibitor. The ideal peptide would clearly be from a target that interacts exclusively with Rac1. However, as we have not yet identified such a peptide we decided to test a peptide from a presumptive Cdc42-only target (N-WASP) and a peptide from a Cdc42 and Rac1 target (PAK). In agreement with the published data [7, 19] , we readily demonstrated that a PAK CRIB peptide can bind directly to both Cdc42 and Rac1, whereas an N-WASP CRIB peptide bound only to Cdc42. In agreement with the above hypothesis we did indeed find that only the peptide that bound effectively to Rac1 inhibited the growth-cone collapse response. Unfortunately, the PAK peptide would be expected to compete for a Rac1 interaction with any target that interacts with the same region of the effector loop, and so, although this observation implicates Rac1 function in the collapse response, it does not cast any light on the nature of the downstream target.
In summary, our results show that a cell-permeable peptide mimic of the amino-acid 17-32 region of the Rac1 effector loop can interact with a range of Rac1 targets and inhibits the growth-cone collapse response. Furthermore, a cell-permeable target-derived peptide that binds back to this region of the Rac1 effector loop also inhibited the collapse response. Both observations demonstrate the feasibility of designing new cell-permeable inhibitors of small GTPases and suggest that Sema3A-induced growth-cone collapse is mediated by an effector molecule that binds to Rac1 amino acids 17-32.
Materials and methods
Peptides
Peptides were synthesised on a 431A Applied Biosystems peptide synthesiser using p-hydroxymethylphenoxymethyl polystyrene resin and standard Fmoc chemistry. All peptides were made as linear sequences with amino-terminal biotin and ε-amino hexanoic acid (εAhx). Biotin allows capture and detection of the peptides and εAhx functions as spacer. After synthesis and deprotection, peptides were purified on a C18 column using reverse phase HPLC and lyophilised.
Constructs
The GST-p67 Phox1-238 and GST-WASP 201-321 constructs were based on pGEX2T and were gifts from Sohail Ahmed (Institute of Neurology, London, UK) and Pontus Aspenström (Ludwig Institute, Uppsala, Sweden), respectively. The GST-PAK 65-137 construct (a gift from Shubha Bagrodia, Cornell University, USA) is based on pGEX-KG and contains mouse PAK3 amino acids 65-137 [28] . Eluted fusion proteins were stored in aliquots in liquid nitrogen. For GST-PAK GTPase-binding domain (GBD) affinity precipitation, the protein was left bound to the GSH-Sepharose beads, which were stored aliquoted in liquid nitrogen. All Rho family proteins were constitutively active mutants (that is, V14RhoA, V12Rac1, V12Cdc42) and were expressed as amino-terminally 9E10 epitope-tagged derivatives using pEFplink ( [29] , gift from Richard Treisman, ICRF, London, UK).
Affinity precipitation
Peptide affinity precipitation of GST-p67 Phox1-238 , GST-PAK 65-137 and GST-WASP 201-321 were performed with 20 µl of peptide-saturated streptavidin agarose (Sigma), which was incubated with 5 µg of each protein in 100 µl buffer Y (50 mM Tris pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% NP-40) with 1 mM dithiothreitol (DTT) for 1 h at 4ºC. Precipitates were washed four times with 1 ml buffer Y and subjected to SDS-PAGE analysis on 10% gels. The proteins were visualised by silver staining. Affinity precipitation of 3BP-1 was performed using a 10 cm plate of quiescent Swiss 3T3 cells per sample. Cells were lysed in 1 ml buffer Y with with 1 mM DTT and Complete protease inhibitors (Boehringer Mannheim). Lysates were cleared by brief centrifugation and incubated with 20 µl peptide-saturated streptavidin agarose for 1 h at 4ºC. Precipitates were washed four times with 1 ml buffer Y and subjected to SDS-PAGE analysis on 10% gels followed by transfer to nitrocellulose filters. 3BP-1 was detected using affinity-purified polyclonal antibody [27] and visualised using enhanced chemiluminescence (ECL). For peptide affinity precipitations of Rho GTPases, COS cells were electroporated with 5 µg of appropriate expression constructs. On the following day the cells were washed twice with cold PBS on ice and lysed in Mg buffer (50 mM Tris pH 7.5, 150 mM NaCl, 10 mM MgCl 2 , 1% NP-40) with 1 mM DTT and Complete protease inhibitors.
Lysates were cleared by brief centrifugation and incubated with 20 µl peptide-saturated streptavidin agarose for 1 h at 4ºC. Precipitates were washed four times with 1 ml Mg buffer and subjected to SDS-PAGE analysis on 12% gels followed by transfer to nitrocellulose filters. 9E10 epitope-tagged GTPases were detected with 9E10 antibody (Santa Cruz Biotechnology) and visualised using ECL.
For peptide competition experiments, COS cells were electroporated with 5 µg of appropriate expression constructs. On the following day the cells were washed twice with cold PBS on ice and lysed in Mg buffer (50 mM Tris pH 7.5, 150 mM NaCl, 10 mM MgCl2, 1% NP-40) with 1 mM DTT and Complete protease inhibitors (Boehringer Mannheim). Lysates were cleared by brief centrifugation. CRIB and BIRC peptides were added to the lysates at 100 µg/ml and the mixture was incubated for 30 min at 4ºC. Sepharose-bound GST-PAK GBD was added and incubation in the same conditions was continued for 5 min. Rac1 peptides were added to the sepharose-bound GST-PAK GBD in the lysis buffer at 200 µg/ml. The mixture was incubated for 20 min at 4ºC. Cell lysates were added in equal volume and incubation continued for 5 min. Precipitates were washed four times with 1 ml Mg buffer and subjected to SDS-PAGE analysis on 12% gels followed by transfer to nitrocellulose filters. 9E10 epitope-tagged GTPases were detected with 9E10 antibody and visualised using ECL.
Growth-cone collapse assay
The collapse assay was performed as described by Eickholt et al. [17] . Briefly, dorsal root ganglia from embryonic day 7 (E7) chick embryos were removed in L-15 medium, cut in half and plated onto chamber slides (Gibco) which had been coated with laminin (20 µg/ml). The explants were kept in DMEM supplemented with 10% FCS, penicillin-streptomycin mix and 20 ng/ml NGF for 20-24 h. Peptides were first diluted to 10 × concentration in water and added to the medium for 1 h. Sema3A-Fc was added to the concentration of 1 µg/ml for 30 min followed by fixation in 4% paraformaldehyde containing 10% sucrose. The actin cytoskeleton was visualised with phalloidin-TRITC and the fraction of neurite tips without lamellipodia and filopodia was determined.
Visualisation of internalised peptides
Dorsal root ganglion explants were prepared as described above. After peptide treatment, samples were washed twice with PBS and fixed in cold acetone:methanol (1:1) for 5 min. Peptides were visualised by extravidin-TRITC (Sigma).
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